Mupirocin - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for mupirocin and what is the scope of freedom to operate?

Mupirocin is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Padagis Us, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Teva, Alembic, Amneal, Encube, and Glenmark Pharms Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for mupirocin. Twenty-one suppliers are listed for this compound.

Sponsor	Phase
Jiangxi Provincial Cancer Hospital	Phase 3
Victoriano Luna Medical Center	Early Phase 1
Future University in Egypt	Phase 2/Phase 3

Sponsor

Phase

Jiangxi Provincial Cancer Hospital

Phase 3

Victoriano Luna Medical Center

Early Phase 1

Future University in Egypt

Phase 2/Phase 3

US Patents and Regulatory Information for mupirocin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Encube	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213076-001	Aug 31, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glenmark Pharms	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	090480-001	Jun 8, 2011	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Israel	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	212465-001	Aug 3, 2022		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213053-001	Nov 16, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glaxosmithkline	BACTROBAN	mupirocin calcium	OINTMENT;NASAL	050703-001	Sep 18, 1995		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Taro	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	065170-001	Sep 23, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Us	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	BX	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Padagis Us	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

OINTMENT;TOPICAL

Dec 4, 2002

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	3
Applicants:	11
NDAs:	15
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	82
Patent Applications:	6,502
Drug Prices:	Drug price trends for mupirocin
Drug Sales Revenues:	Drug sales revenues for mupirocin
What excipients (inactive ingredients) are in mupirocin?	mupirocin excipients list
DailyMed Link:	mupirocin at DailyMed

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Mupirocin - Generic Drug Details

What are the generic drug sources for mupirocin and what is the scope of freedom to operate?

Summary for mupirocin

Recent Clinical Trials for mupirocin

Pharmacology for mupirocin

Medical Subject Heading (MeSH) Categories for mupirocin

Anatomical Therapeutic Chemical (ATC) Classes for mupirocin

US Patents and Regulatory Information for mupirocin

Expired US Patents for mupirocin

Make Better Decisions: Try a trial or see plans & pricing